Effects of Brain Beta Amyloid on Postoperative Cognition and 18F-AV-45-A14: Clinical Evaluation of Florbetapir F 18 (18F-AV-45)
Latest Information Update: 09 May 2025
At a glance
- Drugs Florbetapir F 18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
Most Recent Events
- 01 May 2025 Planned End Date changed from 1 Jun 2023 to 1 Jun 2026.
- 01 May 2025 Planned primary completion date changed from 1 Jun 2023 to 1 Jun 2026.
- 01 May 2025 Status changed from recruiting to active, no longer recruiting.